Transcriptional Activation
"Transcriptional Activation" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Processes that stimulate the GENETIC TRANSCRIPTION of a gene or set of genes.
| Descriptor ID |
D015533
|
| MeSH Number(s) |
G05.308.800
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Transcriptional Activation".
Below are MeSH descriptors whose meaning is more specific than "Transcriptional Activation".
This graph shows the total number of publications written about "Transcriptional Activation" by people in this website by year, and whether "Transcriptional Activation" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1994 | 6 | 17 | 23 |
| 1995 | 8 | 10 | 18 |
| 1996 | 9 | 10 | 19 |
| 1997 | 4 | 15 | 19 |
| 1998 | 6 | 15 | 21 |
| 1999 | 10 | 19 | 29 |
| 2000 | 13 | 21 | 34 |
| 2001 | 7 | 34 | 41 |
| 2002 | 12 | 30 | 42 |
| 2003 | 7 | 32 | 39 |
| 2004 | 5 | 27 | 32 |
| 2005 | 9 | 44 | 53 |
| 2006 | 13 | 20 | 33 |
| 2007 | 6 | 17 | 23 |
| 2008 | 8 | 10 | 18 |
| 2009 | 6 | 28 | 34 |
| 2010 | 10 | 19 | 29 |
| 2011 | 7 | 24 | 31 |
| 2012 | 7 | 21 | 28 |
| 2013 | 7 | 18 | 25 |
| 2014 | 7 | 20 | 27 |
| 2015 | 6 | 19 | 25 |
| 2016 | 3 | 13 | 16 |
| 2017 | 3 | 9 | 12 |
| 2018 | 4 | 4 | 8 |
| 2019 | 3 | 10 | 13 |
| 2020 | 3 | 7 | 10 |
| 2021 | 1 | 7 | 8 |
| 2022 | 0 | 1 | 1 |
| 2023 | 0 | 5 | 5 |
| 2024 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Transcriptional Activation" by people in Profiles.
-
Transcriptional coactivation of NRF2 signaling in cardiac fibroblasts promotes resistance to oxidative stress. J Mol Cell Cardiol. 2024 Sep; 194:70-84.
-
circ-hnRNPU inhibits NONO-mediated c-Myc transactivation and mRNA stabilization essential for glycosylation and cancer progression. J Exp Clin Cancer Res. 2023 Nov 23; 42(1):313.
-
Dimeric p53 Mutant Elicits Unique Tumor-Suppressive Activities through an Altered Metabolic Program. Cancer Discov. 2023 05 04; 13(5):1230-1249.
-
Alternative splicing mediates the compensatory upregulation of MBNL2 upon MBNL1 loss-of-function. Nucleic Acids Res. 2023 02 22; 51(3):1245-1259.
-
Tissue specificity and spatio-temporal dynamics of the p53 transcriptional program. Cell Death Differ. 2023 04; 30(4):897-905.
-
Enhancer-promoter entanglement explains their transcriptional interdependence. Proc Natl Acad Sci U S A. 2023 01 24; 120(4):e2216436120.
-
TPP1 promoter mutations cooperate with TERT promoter mutations to lengthen telomeres in melanoma. Science. 2022 Nov 11; 378(6620):664-668.
-
AR-negative prostate cancer is vulnerable to loss of JMJD1C demethylase. Proc Natl Acad Sci U S A. 2021 09 07; 118(36).
-
Loss of Smad4 promotes aggressive lung cancer metastasis by de-repression of PAK3 via miRNA regulation. Nat Commun. 2021 08 11; 12(1):4853.
-
Enhancer RNA m6A methylation facilitates transcriptional condensate formation and gene activation. Mol Cell. 2021 08 19; 81(16):3368-3385.e9.